Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

655
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
655
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

556
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
556
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.1K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electron-phonon coupling and symmetry breaking in superconducting oxide interfaces near ferroelectric quantum criticality.

Nature materials·2026
Same author

Plasma Cell Vulvitis (Zoon's Vulvitis): A Rare Case Report with Emphasis on Diagnostic Challenge.

Prague medical report·2026
Same author

Systematic review and meta-analysis of protective effects of quercetin in animal models of lung fibrosis and possible mechanism.

International immunopharmacology·2026
Same author

From dust to disease: Neopterin as a marker of silicosis in ceramic industry workers.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same author

Factors associated with anemia among adolescent girls in Western India: insights from a multi-centric cross-sectional study.

Frontiers in global women's health·2026
Same author

Role of novel hematological biomarkers in assessing chronic obstructive pulmonary disease (COPD) patients and their public health implications.

Journal of family medicine and primary care·2026

Related Experiment Video

Updated: Feb 18, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K

Tuberculosis Treated by Multiple Drugs: An Overview.

Gyanendra Singh1, Prashant Kesharwani2, Anand Kumar Srivastava1

  • 1Department of Pharmaceutics, Indian Institute of Technology, Banaras Hindu University, (IIT-BHU), UP-221005, Varanasi, India.

Current Drug Delivery
|November 23, 2017
PubMed
Summary
This summary is machine-generated.

Online communities help individuals with tuberculosis (TB) connect and share information. This review explores TB-related online activities, their benefits, risks, and impact on treatment outcomes.

Keywords:
Mycobacterium tuberculosisPurified Protein Derivative (PPD)Tuberculosisco-infectiontuberculosis regimen

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.1K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.3K

Related Experiment Videos

Last Updated: Feb 18, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.1K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.3K

Area of Science:

  • Medical Research
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) is a bacterial infection with a significant global burden.
  • The internet facilitates connections among individuals with TB, offering support and information exchange.

Purpose of the Study:

  • To identify platforms used by TB patients for interaction.
  • To analyze motivations for and risks of online TB-related activities.
  • To review research on the impact of patient participation on TB outcomes.

Main Methods:

  • Review of existing research and online content concerning TB patient interactions.
  • Analysis of challenges in current TB treatment, including drug resistance and drug interactions.
  • Identification of factors driving the need for improved TB therapies.

Main Results:

  • Online participation offers peer support, advocacy, information sharing, and improved data management.
  • Shortcomings in current TB medications necessitate the development of improved drugs and protocols.
  • Obstacles in utilizing existing drugs and developing new ones are highlighted, focusing on clinical development.

Conclusions:

  • Hurdles in optimizing current TB drugs and developing new ones are discussed.
  • Processes for more efficient TB therapy development are proposed.
  • Enhancing the quality of life for TB patients is a key objective.